Profile data is unavailable for this security.
About the company
Shanghai Haoyuan Chemexpress Co Ltd is a China-based company mainly engaged in the research and development, production and sales of small molecule and new molecule drugs. The molecular building blocks, tool compounds and biochemical reagents business mainly provides milligram to kilogram products and technical services in the drug discovery stage. The active pharmaceutical ingredient and intermediate business products cover anti-tumor, anti-infection, diabetes, cardiovascular and cerebrovascular disease treatment, immune system, nervous system, digestion and other fields. The preparation production business provides customers with pharmaceutical research, registration and production services for preparations. The Company mainly conducts its businesses in the domestic and foreign markets.
- Revenue in CNY (TTM)2.71bn
- Net income in CNY294.90m
- Incorporated2006
- Employees3.58k
- LocationShanghai Haoyuan Chemexpress Co LtdBuilding 3, Lane 1999,Zhangheng Road,Pudong New AreaSHANGHAI 201203ChinaCHN
- Phone+86 2 158338205
- Fax+86 2 158955996
- Websitehttps://www.chemexpress.com.cn/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shanghai Shyndec Pharmaceutical Co Ltd | 9.26bn | 930.27m | 14.31bn | 11.47k | 15.38 | 1.05 | -- | 1.54 | 0.6936 | 0.6936 | 6.91 | 10.17 | 0.4703 | 2.95 | 7.65 | 807,583.30 | 5.41 | 5.14 | 7.83 | 8.21 | 33.20 | 40.86 | 11.50 | 7.82 | 2.62 | -- | 0.003 | 20.02 | -9.38 | -2.16 | 56.62 | 10.55 | -11.46 | 24.57 |
| Zhejiang Medicine Co Ltd | 8.96bn | 1.24bn | 14.40bn | 5.82k | 11.57 | 1.30 | -- | 1.61 | 1.29 | 1.29 | 9.31 | 11.50 | 0.6499 | 2.76 | 5.65 | 1,540,449.00 | 8.19 | 5.31 | 10.15 | 6.93 | 39.47 | 36.97 | 12.60 | 7.68 | 2.01 | -- | 0.0784 | 30.91 | 20.29 | 5.88 | 170.11 | 27.62 | 3.74 | -18.03 |
| Guobang Pharma Ltd | 5.94bn | 872.95m | 15.05bn | 4.00k | 17.16 | 1.82 | -- | 2.53 | 1.57 | 1.57 | 10.68 | 14.80 | 0.5603 | 3.06 | 7.04 | 1,484,531.00 | 8.20 | 9.52 | 10.33 | 12.47 | 24.67 | 27.10 | 14.64 | 14.91 | 2.30 | -- | 0.1038 | 24.76 | 10.12 | 9.15 | 27.61 | 19.94 | -7.08 | -- |
| Shanghai Haoyuan Chemexpress Co Ltd | 2.71bn | 294.90m | 15.08bn | 3.58k | 50.92 | 4.84 | -- | 5.56 | 1.40 | 1.40 | 12.85 | 14.67 | 0.504 | 1.10 | 3.98 | 757,880.40 | 5.37 | 5.94 | 7.32 | 7.80 | 48.93 | 45.09 | 10.66 | 11.74 | 1.46 | 7.54 | 0.4102 | 16.95 | 20.75 | 40.89 | 58.17 | 22.38 | 71.42 | -- |
| Nanjing King-Frind Bchmcl Phrmctcl C Ltd | 3.76bn | 649.83m | 15.77bn | 1.36k | 23.93 | 2.33 | -- | 4.19 | 0.4079 | 0.4079 | 2.35 | 4.18 | 0.3812 | 0.6322 | 3.82 | 2,765,677.00 | 6.59 | 8.38 | 8.99 | 12.03 | 41.12 | 44.95 | 17.28 | 19.72 | 1.35 | -- | 0.2644 | 23.22 | -0.1984 | 9.70 | 536.09 | 6.43 | 34.44 | -6.04 |
| Zhejiang Jiuzhou Pharmaceutical Co Ltd | 5.36bn | 722.87m | 15.94bn | 5.00k | 22.09 | 1.82 | -- | 2.98 | 0.8113 | 0.8113 | 6.07 | 9.84 | 0.493 | 1.97 | 4.84 | 1,070,948.00 | 6.65 | 9.23 | 7.91 | 12.19 | 34.65 | 33.78 | 13.50 | 15.64 | 2.42 | -- | 0.0152 | 39.55 | -6.57 | 20.67 | -41.34 | 20.58 | 22.64 | 8.45 |
| China Resources Jingzhng Phrmctcl Co Ltd | 4.40bn | 837.30m | 16.18bn | 4.18k | 19.27 | 4.26 | -- | 3.68 | 1.32 | 1.32 | 6.94 | 5.98 | 0.6755 | 3.53 | 11.30 | 1,051,350.00 | 14.12 | 11.45 | 23.31 | 16.72 | 60.96 | 64.04 | 20.91 | 18.23 | 1.33 | -- | 0.0348 | 93.25 | -2.59 | 12.61 | 9.67 | 11.20 | 30.67 | 36.85 |
Data as of Feb 06 2026. Currency figures normalised to Shanghai Haoyuan Chemexpress Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
14.08%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Zhong Ou Asset Management Co., Ltdas of 30 Jun 2025 | 8.26m | 3.91% |
| Harvest Fund Management Co., Ltd.as of 30 Jun 2025 | 6.57m | 3.11% |
| Schroder Investment Management (Hong Kong) Ltd.as of 30 Nov 2025 | 4.41m | 2.08% |
| GF Fund Management Co., Ltd.as of 30 Jun 2025 | 2.98m | 1.41% |
| Huashang Fund Management Co., Ltd.as of 30 Jun 2025 | 1.72m | 0.81% |
| China Southern Asset Management Co., Ltd.as of 30 Jun 2025 | 1.62m | 0.76% |
| Tian Hong Asset Management Co., Ltd.as of 30 Jun 2025 | 1.20m | 0.57% |
| HuaAn Fund Management Co., Ltd.as of 30 Jun 2025 | 1.04m | 0.49% |
| ICBC UBS Asset Management Co. Ltd.as of 30 Jun 2025 | 1.00m | 0.47% |
| China Asset Management Co., Ltd.as of 30 Jun 2025 | 984.73k | 0.47% |
More ▼
Data from 30 Jun 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
